Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFiltronic Regulatory News (FTC)

Share Price Information for Filtronic (FTC)

Share Price is delayed by 15 minutes
Get Live Data
392.50    2.50 (0.64%)
Bid:
390.00
Ask:
395.00
Spread: 5.00 (1.282%)
Market Cap: £863.28m
FTC Live PriceLast checked at - London Stock Exchange

Intraday Filtronic Share Chart

Contract Win

23 Jul 2024 07:00

RNS Number : 3643X
Filtronic PLC
23 July 2024
 

 

23 July 2024

Filtronic plc

("Filtronic")

 

CONTRACT WIN

 

$9m contract win from SpaceX and vesting of share warrants

 

Filtronic plc (AIM: FTC), the designer and manufacturer of products for the aerospace, defence, telecoms infrastructure and critical communications markets, is pleased to announce the receipt of a follow-on production order from SpaceX.

 

The order is irrevocable, valued at $9m (£7.1m), and represents a continuation of demand for the E-band solid state power amplifier ("SSPA") modules to support the ongoing deployment of SpaceX's Starlink constellation which provides high-speed, low-latency high-speed internet to users all around the world. It is anticipated the order will be fulfilled in the current financial year.

 

The order has been placed under the framework of the Strategic Partnership, signed in April 2024, with the vesting of a further 2,171,211 share warrants. Under the terms of the agreement, as disclosed in the announcement on 24 April 2024, the Company issued two separate tranches of warrants with this vesting of warrants being part of tranche 1. Tranche 1 relates to the supply of E-band SSPAs with a total of 8,684,844 share warrants now vested to date, representing 4%, of the maximum 5%, of Company's share capital at the time of the signed agreement.

 

Nat Edington, Chief Executive Officer, said: "We are delighted to receive this further order from our partner, SpaceX, as we continue to support the rollout of the Starlink constellation. The order demonstrates the continued significant role we are playing in helping SpaceX achieve their mission."

 

 

Enquiries:

Filtronic plc

Tel. 01740 618800 or investor.relations@filtronic.com

Nat Edington (Chief Executive Officer)

 

Michael Tyerman (Chief Financial Officer)

 

 

Cavendish Capital Markets Limited

Tel. 020 7220 0500

Jonny Franklin-Adams/George Dollemore (Corporate Finance)

Sunila de Silva (ECM)

 

 

Walbrook PR Limited

Tel. 020 7933 8780 or filtronic@walbrookpr.com

Nick Rome/Jospeh Walker

 

Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTBRGDRSSDDGSD
Date   Source Headline
1st Apr 20222:17 pmRNSHolding(s) in Company
28th Mar 20222:11 pmRNSDirector/PDMR Dealing
17th Mar 20228:43 amRNSHolding(s) in Company
8th Mar 20221:36 pmRNSDirector/PDMR Dealing
28th Feb 20224:27 pmRNSExercise of Options and Issue of Equity
21st Feb 20224:03 pmRNSHolding(s) in Company
8th Feb 20227:00 amRNSHalf-Year Results to 30 November 2021
2nd Feb 202211:53 amRNSExercise of Options and Issue of Equity
2nd Nov 20217:00 amRNSAppointment of new Non-Executive Chairman
28th Oct 20213:14 pmRNSResult of AGM
28th Oct 20217:00 amRNSAGM Statement & Notice of Interim Results
21st Oct 20213:32 pmRNSHolding(s) in Company
20th Oct 20217:00 amRNSNew Contract Award
14th Sep 20211:06 pmRNSExercise of Options and Issue of Equity
8th Sep 20213:41 pmRNSPosting of Annual Report & Notice of AGM
3rd Aug 20217:00 amRNS2021 Final Results
16th Jul 20217:00 amRNSBrand Refresh
24th Jun 202112:32 pmRNSGrant of Options
17th Jun 20217:00 amRNSTrading Update and Notice of Results
9th Jun 20212:00 pmRNSPrice Monitoring Extension
7th Jun 20214:41 pmRNSSecond Price Monitoring Extn
7th Jun 20214:35 pmRNSPrice Monitoring Extension
7th Jun 20217:00 amRNSInitiation of research coverage by Edison
3rd Jun 20218:19 amEQSFiltronic (FTC): Initiation - Building a stronger connection
1st Jun 20213:51 pmRNSHolding(s) in Company
29th Apr 20211:35 pmRNSExercise of Options and Issue of Equity
29th Apr 20219:36 amRNSFiltronic wins 2021 Queen's Award for Enterprise
11th Mar 20211:07 pmRNSExercise of Options and Issue of Equity
4th Mar 20211:28 pmRNSDirector/PDMR Dealing
1st Mar 20214:02 pmRNSHolding(s) in Company
25th Feb 20212:06 pmRNSSecond Price Monitoring Extn
25th Feb 20212:00 pmRNSPrice Monitoring Extension
25th Feb 202111:05 amRNSSecond Price Monitoring Extn
25th Feb 202111:00 amRNSPrice Monitoring Extension
24th Feb 20217:00 amRNSDirector/PDMR Share Purchase
2nd Feb 20217:00 amRNS2021 Half-Year Results
12th Jan 20217:00 amRNSNew UK Defence Contract Award & Notice of Results
14th Dec 20207:00 amRNSDirectorate Change
8th Dec 20202:34 pmRNSHolding(s) in Company
13th Nov 20204:40 pmRNSSecond Price Monitoring Extn
13th Nov 20204:35 pmRNSPrice Monitoring Extension
29th Oct 202011:57 amRNSResult of AGM
29th Oct 20207:00 amRNSAGM Statement
15th Oct 20205:03 pmRNSHolding(s) in Company
15th Oct 20205:03 pmRNSHolding(s) in Company
25th Sep 202010:20 amRNSAdoption of Share Option Plan and Grant of Options
18th Aug 20204:41 pmRNSPosting of Annual Report & Notice of AGM
4th Aug 20209:00 amRNSAppointment of new CEO
4th Aug 20207:00 amRNS2020 Audited Full Year Results
6th Jul 20207:00 amRNSNew Contract Award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.